The SPIRO-MOTE Study

计划入组 40 人 · 首次发布于 2023 年 7 月 25 日

Synergistic Pharmacologic Intervention for Prevention of ROP (SPIPROP Study)

计划入组 14 人 · 首次发布于 2015 年 1 月 22 日

HPVPro Study: Comparison of HPV Detection in Clinician-collected Cervical Swabs and Self-sampled Cervicovaginal Swabs

计划入组 1,044 人 · 首次发布于 2019 年 10 月 21 日

SPIRO-2101

SPIRO-2110

SPIRO-2102

MATTIOLI SANDRO

Italy

Spero Therapeutics

United States

PROTAC Technology Emerges as Next-Generation Approach for IDO1-Targeted Cancer Immunotherapy

GSK's Oral Carbapenem Antibiotic Tebipenem HBr Succeeds in Phase 3 Trial, Setting Stage for FDA Filing

Spero Therapeutics Halts SPR720 Development After Phase IIa Failure